One in three South Korean patients seriously ill with COVID-19 showed an improvement in their condition after being given Gilead Sciences Inc's antiviral remdesivir, Reuters news agency reported on Monday quoting health authorities.
More research was needed to determine if the improvement was attributable to the drug or other factors such as patients' immunity and other therapies, authorities said.
No comments:
Post a Comment